| scholarly article | Q13442814 |
| P50 | author | Lucinda Bateman | Q79198940 |
| P2093 | author name string | Neeraj Agarwal | |
| Alan R Light | |||
| Ronald W Hughen | |||
| Anita Y Kinney | |||
| Andrea T White | |||
| Eli Iacob | |||
| Kathleen C Light | |||
| Hannah Aizad | |||
| Timothy A VanHaitsma | |||
| P2860 | cites work | Assessment of mood: Guides for clinicians | Q22252377 |
| Loneliness predicts pain, depression, and fatigue: understanding the role of immune dysregulation | Q24631784 | ||
| Identification of marker genes for differential diagnosis of chronic fatigue syndrome | Q24648930 | ||
| Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy | Q26864943 | ||
| The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group | Q28241826 | ||
| The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? | Q33312542 | ||
| Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses | Q33798326 | ||
| Assessment of a 44 gene classifier for the evaluation of chronic fatigue syndrome from peripheral blood mononuclear cell gene expression | Q33867419 | ||
| Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy | Q33965263 | ||
| Mechanisms of cancer-related fatigue | Q34004732 | ||
| The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system | Q34022196 | ||
| Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study | Q34317938 | ||
| I’m so tired: biological and genetic mechanisms of cancer-related fatigue | Q34543971 | ||
| Gender differences in fibromyalgia and other related syndromes | Q34613364 | ||
| Gene profiling of patients with chronic fatigue syndrome/myalgic encephalomyelitis | Q34879636 | ||
| Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. | Q35061216 | ||
| Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents | Q35120883 | ||
| Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome | Q35219064 | ||
| Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? | Q35229735 | ||
| Plasma oxytocin is related to lower cardiovascular and sympathetic reactivity to stress | Q35578272 | ||
| Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls | Q35666632 | ||
| The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor | Q35838409 | ||
| Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. | Q35968834 | ||
| Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue | Q36206254 | ||
| Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer | Q36230718 | ||
| Mitochondria-related gene expression changes are associated with fatigue in patients with nonmetastatic prostate cancer receiving external beam radiation therapy | Q36336549 | ||
| The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review | Q36687586 | ||
| Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue | Q36701431 | ||
| Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer | Q37162112 | ||
| Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects | Q37376370 | ||
| Cancer-related fatigue: the approach and treatment | Q37390084 | ||
| Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy | Q37390104 | ||
| Critical role of nociceptor plasticity in chronic pain | Q37603560 | ||
| Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster | Q37633785 | ||
| Pain and purinergic signaling | Q37636835 | ||
| CXCR4 and cancer | Q37769282 | ||
| Biological mechanisms of chronic fatigue | Q37834153 | ||
| Biology and pathophysiology of the amyloid precursor protein | Q37869935 | ||
| Fatigue, brain, behavior, and immunity: summary of the 2012 Named Series on fatigue | Q38042268 | ||
| Hormonal regulation of beta2-adrenergic receptor level in prostate cancer | Q38291307 | ||
| Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer | Q38776802 | ||
| P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain | Q39393829 | ||
| SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer | Q39427860 | ||
| Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells | Q39840981 | ||
| Peripheral blood gene expression in postinfective fatigue syndrome following from three different triggering infections. | Q40310501 | ||
| Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment? | Q41528091 | ||
| Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analog | Q46471817 | ||
| Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells. | Q46471904 | ||
| Dorsal root ganglion neurons innervating skeletal muscle respond to physiological combinations of protons, ATP, and lactate mediated by ASIC, P2X, and TRPV1. | Q46570470 | ||
| Chronic fatigue syndrome/myalgic encephalomyelitis: an update. | Q51515704 | ||
| Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study | Q58047395 | ||
| Post-cancer fatigue is not associated with immune activation or altered cytokine production | Q59200524 | ||
| P433 | issue | 12 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 2983-2995 | |
| P577 | publication date | 2013-09-06 | |
| P1433 | published in | Psychoneuroendocrinology | Q7256450 |
| P1476 | title | Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome | |
| P478 | volume | 38 |
| Q35875673 | A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome |
| Q98163552 | A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease |
| Q26859215 | CXCL12 chemokine and GABA neurotransmitter systems crosstalk and their putative roles |
| Q36332266 | Cancer-related fatigue--mechanisms, risk factors, and treatments |
| Q30384063 | Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain. |
| Q39937097 | Gene Expression Profiling of Evening Fatigue in Women Undergoing Chemotherapy for Breast Cancer |
| Q50333926 | Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model |
| Q46893422 | Inflammatory pathway genes associated with inter-individual variability in the trajectories of morning and evening fatigue in patients receiving chemotherapy. |
| Q61804879 | Multidimensional Comparison of Cancer-Related Fatigue and Chronic Fatigue Syndrome: The Role of Psychophysiological Markers |
| Q62675748 | Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop? |
| Q92081436 | Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome |
| Q38796656 | Quality of sleep in patients receiving androgen deprivation therapy for prostate cancer |
| Q37649201 | The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). |
Search more.